Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial von O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof

Volltext

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Be... von PATEL, Jyoti D, SOCINSKI, Mark A, GUBA, Susan C, JINGYI LIU, FRIMODT-MOLLER, Bente, JOHN, William J, OBASAJU, Coleman K, PENNELLA, Eduardo J, BONOMI, Philip, GOVINDAN, Ramaswamy, GARON, Edward B, REYNOLDS, Craig H, SPIGEL, David R, OLSEN, Mark R, HERMANN, Robert C, JOTTE, Robert M, BECK, Thaddeus, RICHARDS, Donald A

Volltext

DISTANCE CORRELATION METHODS FOR DISCOVERING ASSOCIATIONS IN LARGE ASTROPHYSICAL DATABASES von Martinez-Gomez, Elizabeth, Richards, Mercedes T, Richards, Donald St P

Volltext

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers von VON HOFF, Daniel D, STEPHENSON, Joseph J, FITCH, Tom R, WASSERMAN, Ernesto, FERNANDEZ, Cristian, GREEN, Sylvan, SUTHERLAND, William, BITTNER, Michael, ALARCON, Arlet, MALLERY, David, PENNY, Robert, ROSEN, Peter, LOESCH, David M, BORAD, Mitesh J, ANTHONY, Stephen, JAMESON, Gayle, BROWN, Susan, CANTAFIO, Nina, RICHARDS, Donald A

Volltext

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial von Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Yang, Zhao, Antal, Joyce M, Morris, Shannon R, O'Shaughnessy, Joyce

Volltext

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 von JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John

Volltext

Schur Complement Based Analysis of MIMO Zero-Forcing for Rician Fading von Siriteanu, Constantin, Takemura, Akimichi, Kuriki, Satoshi, Richards, Donald St. P., Shin, Hyundong

Volltext

Value orientations and support for guaranteed income von Richards, Donald R., Steiger, Thomas L

Volltext

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study von FUCHS, Charles S, MARSHALL, John, BARRUECO, José, MITCHELL, Edith, WIERZBICKI, Rafal, GANJU, Vinod, JEFFERY, Mark, SCHULZ, Joseph, RICHARDS, Donald, SOUFI-MAHJOUBI, Raoudha, WANG, Benjamin

Volltext

Kurtosis tests for multivariate normality with monotone incomplete data von Yamada, Tomoya, Romer, Megan M., Richards, Donald St. P.

Volltext

Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer von Dickler, Maura N, Saura, Cristina, Richards, Donald A, Krop, Ian E, Cervantes, Andrés, Bedard, Philippe L, Patel, Manish R, Pusztai, Lajos, Oliveira, Mafalda, Cardenas, Alison K, Cui, Na, Wilson, Timothy R, Stout, Thomas J, Wei, Michael C, Hsu, Jerry Y, Baselga, José

Volltext

R.A.P.I.D. (Root Aggregated Prioritized Information Display): A single screen display for efficient digital triaging of medical reports von Ford, John P., Huang, Liying, Richards, Donald St.P., Ambinder, Edward P., Rosenberger, James L.

Volltext

Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer von BENDELL, Johanna C, NEMUNAITIS, John, VUKELJA, Sasha J, HAGENSTAD, Christopher, CAMPOS, Luis T, HERMANN, Robert C, SPORTELLI, Peter, GARDNER, Lesa, RICHARDS, Donald A

Volltext

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer von JONES, Stephen E, SAVIN, Michael A, SANDBACH, John, HYMAN, William J, KHANDELWAL, Pankaj, NEGRON, Angel G, RICHARDS, Donald A, ANTHONY, Stephen P, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Walter G, ASMAR, Lina, HOLMES, Frankie Ann, O'SHAUGHNESSY, Joyce A, BLUM, Joanne L, VUKELJA, Svetislava, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert

Volltext

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: Th... von Hanna, Nasser, Neubauer, Marcus, Yiannoutsos, Constantin, McGarry, Ronald, Arseneau, James, Ansari, Rafat, Reynolds, Craig, Govindan, Ramaswamy, Melnyk, Anton, Fisher, William, Richards, Donald, Bruetman, Daniel, Anderson, Thomas, Chowhan, Naveed, Nattam, Sreenivasa, Mantravadi, Prasad, Johnson, Cynthia, Breen, Tim, White, Angela, Einhorn, Lawrence

Volltext

Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma von O'Reilly, Eileen M., Barone, Diletta, Mahalingam, Devalingam, Bekaii-Saab, Tanios, Shao, Spencer H., Wolf, Julie, Rosano, Molly, Krause, Silva, Richards, Donald A., Yu, Kenneth H., Roach, James M., Flaherty, Keith T., Ryan, David P.

Volltext

Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study von Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Xiao, Jie, Sorrentino, Jessica, Horton, Janet, O'Shaughnessy, Joyce

Volltext

Finite-sample inference with monotone incomplete multivariate normal data, I von Chang, Wan-Ying, Richards, Donald St.P.

Volltext

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial von Golan, Talia, Geva, Ravit, Richards, Donald, Madhusudan, Srinivasan, Lin, Boris Kin, Wang, Haofei Tiffany, Walgren, Richard A., Stemmer, Salomon M.

Volltext

Exact ZF Analysis and Computer-Algebra-Aided Evaluation in Rank-1 LoS Rician Fading von Siriteanu, Constantin Costi, Takemura, Akimichi, Koutschan, Christoph, Kuriki, Satoshi, St. P. Richards, Donald, Hyundong Shin

Volltext